Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Pacira Pharmaceuticals Inc (NASDAQ:PCRX)

Delayed Data
As of Jul 26
 -0.97 / -2.58%
Today’s Change
Today|||52-Week Range

Stock Price Forecast

The 10 analysts offering 12-month price forecasts for Pacira Pharmaceuticals Inc have a median target of 74.50, with a high estimate of 105.00 and a low estimate of 36.00. The median estimate represents a +103.05% increase from the last price of 36.69.

Analyst Recommendations

The current consensus among 10 polled investment analysts is to Buy stock in Pacira Pharmaceuticals Inc. This rating has held steady since July, when it was unchanged from a Buy rating.Move your mouse over past
months for detail


Earnings and Sales Forecasts

Current Quarter

Earnings per Share
Reporting Date
Jul 28

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly -247.14%
Growthannually -1,116.68%


Growthquarterly 3.55%
Growthannually 13.44%
Key to the earnings and sales forecast charts.